Qiagen N.V. (NYSE: QGEN) has announced two strategic partnerships designed to revolutionize minimal residual disease (MRD) ...

QIAGEN expands its oncology diagnostics with partnerships advancing minimal residual disease testing for solid tumors & blood ...

The deals cover development and commercialization of next-generation sequencing and digital PCR assays for minimal residual disease detection.

Qiagen MinElute PCR Purification, Zymo Research DNA Clean and Concentrator-5, Invitrogen ChargeSwitch-Pro PCR Purification, and Beckman Coulter AMPure XP. HS-AFM avoids amplification artifacts present ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

The global automated nucleic acid extraction systems market is set to experience significant growth, driven by the rising demand for efficient diagnostic solutions. From an estimated USD 4,643.3 ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new commercial partnership and co-marketing agreement with ID Solutions, a French provider of high-quality digital PCR (dPCR) ...

The global Liquid Handling System Market, valued at US$4.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.0%, ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient ...

The Trump administration has decided to permit the sale of devices that enable standard firearms to fire like machine guns, a move that one person familiar with the matter said was “by far the ...

In this episode of The David Frum Show, The Atlantic’s David Frum breaks down what he calls “the week of the four scams”—a stunning display of misinformation and corruption from President ...